title: Atypical hyperplasia of the breast--risk assessment and management options.
authors.affiliation: From the Departments of Oncology (L.C.H.), Surgery (A.C.D.), and Internal Medicine (K.G.), Mayo Clinic, Rochester, MN; the Department of Endocrinology and Metabolism Medicine, University of Virginia, Charlottesville (R.J.S.); and the Department of Biostatistics, Vanderbilt University, Nashville (W.D.D.).
authors.forename: Lynn C
authors.initials: LC
authors.lastname: Hartmann
authors.forename: Amy C
authors.initials: AC
authors.lastname: Degnim
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Santen
authors.forename: William D
authors.initials: WD
authors.lastname: Dupont
authors.forename: Karthik
authors.initials: K
authors.lastname: Ghosh
mesh_terms: D000328:Adult; D001706:Biopsy; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000473:pathology* / Q000517:prevention & control; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000473:pathology / Q000628:therapy; D015994:Incidence; D008279:Magnetic Resonance Imaging; D008408:Mastectomy; D008875:Middle Aged; D018570:Risk Assessment; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
chemical_list: D020845:Selective Estrogen Receptor Modulators